Frequency of EGFR mutations in Greek non-small-cell lung cancer (NSCLC) patients

被引：0
|
作者：
Murray, Samuel [1 ]
Papadopoulou, Eirini [1 ]
Nasioulas, George [1 ]
机构：
[1] GENEKOR SA, Gerakas, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21141
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Frequency of EGFR mutations in peruvian patients with non-small cell lung cancer.
    Gomez de la Torre, Juan C.
    Storace, Angelo
    Piscocha, Christian
    Landa, Jose
    Roe, Carlos
    Roe, Eduardo
    Barletta, Claudia
    Mas, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Frequency and types of EGFR mutations in Moroccan patients with non-small cell lung cancer
    Sow, Mohamed Lemine
    El Yacoubi, Hind
    Moukafih, Badreddine
    Balde, Salif
    Akimana, Gloria
    Najem, Salma
    El Khoyaali, Siham
    Abahssain, Halima
    Chaibi, Aicha
    Khan, Shah Zeb
    Trapani, Dario
    Benzekri, Asmae
    Ghaouti, Merieme
    Gamra, Lamia
    Mestari, Amina
    Kettani, Fouad
    Rahali, Younes
    Mrabti, Hind
    Elghissassi, Ibrahim
    Errihani, Hassan
    TUMORI JOURNAL, 2021, 107 (04): : 335 - 340
  • [33] HER2 AND BRAF MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)
    Estival, Anna
    Carcereny, Enric
    Indacochea, Alberto
    Luis Ramirez, Jose
    Moran, Teresa
    Luis Cuadra, Jose
    Vila, Laia
    Gil, Maria
    Botia, Monica
    Perez, M.
    Tierno, M.
    Capdevila, Laia
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S957 - S957
  • [34] Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
    Zhang, Qi
    Nong, Jingying
    Wang, Jinghui
    Yan, Zhuohong
    Yi, Ling
    Gao, Xin
    Liu, Zhidong
    Zhang, Hongtao
    Zhang, Shucai
    ONCOLOGY LETTERS, 2019, 17 (04) : 3799 - 3807
  • [35] Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
    Rossi, Sabrina
    Di Noia, Vincenzo
    Tonetti, Laura
    Strippoli, Antonia
    Basso, Michele
    Schinzari, Giovanni
    Cassano, Alessandra
    Leone, Antonio
    Barone, Carlo
    D'Argento, Ettore
    FUTURE ONCOLOGY, 2018, 14 (10) : 919 - 926
  • [36] POOLED ANALYSIS OF CLINICAL OUTCOMES FOR PATIENTS WITH EGFR MUTATIONS IN NON-SMALL-CELL LUNG CANCER: AN UPDATE
    Paz-Ares, L.
    Soulieres, D.
    Klughammer, B.
    Bara, I.
    Moecks, J.
    Mok, T. S. K.
    ANNALS OF ONCOLOGY, 2012, 23 : 411 - 411
  • [37] IMMUNOHISTOCHEMISTRY (IHC) WITH EGFR MUTATION-SPECIFIC MONOCLONAL ANTIBODIES (MABS) FOR SCREENING EGFR MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)
    Simonetti, S.
    Molina, M. A.
    Mayo, C.
    De Aguirre, I.
    Queralt, C.
    Moran, T.
    Viteri, S.
    Benlloch, S.
    Taron, M.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 125 - 125
  • [38] Testing for EGFR mutations in patients with non-small-cell lung cancer at Musgrove Park Hospital, Taunton
    Saxby, H.
    Karina, M.
    Jankowska, P.
    Faulkner, C.
    LUNG CANCER, 2013, 79 : S6 - S7
  • [39] Targeting EGFR in non-small-cell lung cancer
    Doroshow, JH
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 200 - 202
  • [40] Multicenter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations
    Cardenal, Felipe
    Moran, Teresa
    Queralt, Cristina
    Porta, Ruth
    Camps, Carlos
    Majem, Margarita
    Lopez-Vivanco, Guillermo
    Isla, Dolores
    Provencio, Mariano
    Sanchez, Jose Javier
    Taron, Miquel
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S324 - S325
12345